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Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission
At any time, an emerging, lethal, and highly transmissible pathogen might pose a risk of being spread globally because of the interconnectedness of the global population. 1,2 Emerging epidemic threats are occurring with increasing scale, duration, and effect, often disrupting travel and trade, and damaging both national and regional economies. 3, 4 Even geographically limited outbreaks such as the Ebola virus disease in Africa might have a global effect.
Preparing for epidemic threats is not a static or binary (prepared or unprepared) exercise, but a dynamic state reflecting the constantly changing world. Countries prepare in different ways based on their interpretation of disease risks and international agreements such as the International Health Regulations (IHR). The IHR were introduced in 1969 to prevent spread of specific serious diseases between countries and set out preparedness measures at international borders to stop disease spread. The 2005 revisions to the IHR reflect changes across multiple dimensions, requiring countries to develop preparedness capacities to detect and respond to outbreaks where and when they occur, supported by international partners to respond when outbreaks cannot be contained locally. 5 However, disruptive factors have emerged at a greater pace over the past decade, creating a new ecology that requires novel strategies for preparedness. These factors include dealing with the increasing human population density and connectivity, harnessing novel data streams and new technological advances to manage epidemics, mitigating false information on social networks, to creating informal technical networks that can work together when political forces fail to do so.
Do the recent outbreaks of Ebola virus disease, Middle East respiratory syndrome coronavirus, and yellow fever reflect this changing context of disruptions requiring dynamic responses? These outbreaks show that countries are at various stages of preparedness, and many have underdeveloped preparedness plans and response capabilities with weak or non-existent strategies to mitigate disruptive factors. 6, 7 Many countries face severe difficulties in providing universal health coverage, for example, and might overlook timely investments for threats that demand greater health-care facility or workforce requirements. 8, 9 Other challenges include shifts in within-country and between-country cooperation, the evolving need for transdisciplinary, cross-sectoral approaches and social participation, 2, 3, 8, 9 and effective leadership, coordination, and financing of local national and international partners. 10 Against this backdrop, the Lancet Infectious Diseases Commission on Preparedness for Emerging Epidemic Threats was formed in mid-2019 to examine the importance of this new ecology and its disruptive factors that have resulted in an underprepared world, whether current planning assumptions still hold, and what mitigation measures need to be introduced.
A sample of the new ecology, its disruptive factors, and how they manifest are shown in the table. Preparedness plans must take these factors into account to succeed and those that do not will not have the resilience and capability to fully respond. These factors are political and institutional factors that include influential stakeholders and decision-making forces; social factors that link individuals and communities, through exchange of goods and information, and building relationships that ensure societal cohesiveness; environmental factors that influence pathogens and hosts, contribute to biodiversity and how diseases emerge and spread, these factors affect interaction between humans, vertebrate animals, and arthropod vectors, and influence human development and health systems; and pathogenic factors that define the biological basis of epidemic emergence and antimicrobial resistance, host-pathogen interactions, and available interventions to address these epidemics.
The Lancet Infectious Diseases Commission will discuss disruptive factors and how preparedness planning must consider this new ecology by exploring current preparedness platforms and their vulnerability to disruptive factors; by addressing key disruptions, iden tifying possible solutions, and providing recommendations for countries to strengthen preparedness; by developing a multidisciplinary approach including To tackle the wide-ranging issues, the Commission has brought together experts from academic, public health, policy making, international, non-governmental, and corporate institutions. They bring local and global knowledge and experience, including policy-making and field response, human and animal health (including One Health) approaches, and novel developments in communications, information technology, analytics, public health, diagnostics, and therapeutics. The Commission aims to deliver the report by 2021 and will include key recommendations for countries and international stakeholders, and monitoring indicators to evaluate the effectiveness of preparedness initiatives over time.
*Vernon J Lee, Ximena Aguilera, David Heymann, Annelies Wilder-Smith, for The Lancet Infectious Diseases Commission
Ministry of Health, Singapore (VJL); Saw Swee Hock School of Public Health, Singapore 117549 (VJL); Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Chile (XA); and London School of Hygiene & Tropical Medicine, London, UK (DH, AW-S) vernonljm@hotmail.com
The Mok Hing Yiu Charitable Foundation is the sole sponsor for the Lancet Infectious Diseases Commission meetings and travel for some commissioners. The foundation is not involved in the technical discussions, data analysis, and drafting of the report. This Comment was written on the behalf of the Lancet Infectious Diseases Commission on Preparedness for Emerging Epidemic Threats; see appendix (pp 1-2) for the Commissions author list.
